One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

Lesions may affect the face, ears, and scalp, but the palms and soles ... Guttate psoriasis may represent the initial stage of chronic plaque-type psoriasis. On resolution, post-inflammatory ...

Researchers conducted a retrospective study to investigate the effectiveness of brodalumab for treating difficult-to-manage ...

Discover a recent study from 12 hospitals across China that has shed new light on personalised care for plaque psoriasis.

Guselkumab achieved clear or almost clear skin in 74.2% of patients with moderate plaque psoriasis, compared to 12.4% on placebo. The VISIBLE study showed rapid and significant clearance of scalp ...

Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low BSA moderate PsO with involvement across four special sites (scalp, face, skin folds ...

Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...

First-of-its-kind Phase 3b study shows TREMFYA ® achieved statistical significance across all primary and secondary endpoints in low body surface area psoriasis with special site involvement ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...

moderate plaque psoriasis (PsO) with special site involvement who had failed topical treatment. Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low ...